ロード中...
Pharmacogenomics and COVID-19: clinical implications of human genome interactions with repurposed drugs
The outbreak of Coronavirus disease 2019 (COVID-19) has evolved into an emergent global pandemic. Many drugs without established efficacy are being used to treat COVID-19 patients either as an offlabel/compassionate use or as a clinical trial. Although drug repurposing is an attractive approach with...
保存先:
| 出版年: | Pharmacogenomics J |
|---|---|
| 第一著者: | |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Nature Publishing Group UK
2021
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7859465/ https://ncbi.nlm.nih.gov/pubmed/33542445 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41397-021-00209-9 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|